Promoting Chemistry’s Positive Public Image
Jan25

Promoting Chemistry’s Positive Public Image

I had an opportunity earlier this month to write a short “Inside Science” piece for the Charlotte Observer and Raleigh News & Observer newspapers. These two publications are among those under the McClatchy Company umbrella of 30 U.S. newspapers with a history dating back to 1857 and the founding of what is now The Sacramento Bee. I was offered great latitude in writing a piece that was to run between 401 and 426 words....

Read More
Must-See ACS Webinar: Superbugs and Drug Development
Feb26

Must-See ACS Webinar: Superbugs and Drug Development

One of science journalism’s expert voices, author Maryn McKenna, will be the guest on this Thursday’s ACS Webinar Joy of Science series at 2:00 – 3:00 pm Eastern time. Free, as always, you can sign up to participate at this link. McKenna’s book, SUPERBUG: The Fatal Menace of MRSA, is a thorough and accessible investigation of the reemergence of lethal bacterial infections while new drug development lags. The...

Read More
Why Isn’t Caffeine Called “Theoanaleptine”?
Feb13

Why Isn’t Caffeine Called “Theoanaleptine”?

This question came to me as I read last week’s C&EN cover story by Dr. Lauren K. Wolf on caffeine toxicity entitled, “Caffeine Jitters.” By the way, read it if you haven’t — it’s open-access on C&EN right now and remains the most-read (last 7 days), most-commented (last 30 days), and most-shared (last 30 days) article since it appeared. Lauren did a terrific job of sifting through decades of...

Read More
HHMI and Duke Celebrate the Lefkowitz Chemistry Nobel
Oct11

HHMI and Duke Celebrate the Lefkowitz Chemistry Nobel

As discussed in my previous post, I took a personal day off from work yesterday to bask in the excitement of a university community celebrating a Nobel prize for one of its most beloved researchers, Dr. Robert “Bob” Lefkowitz, MD. He joined Duke in 1973 when, he says, “it was not the powerhouse it is today.” Lefkowitz will share the prize with his former trainee, Brian Kobilka, MD, now at Stanford University. I...

Read More
Lefkowitz and Kobilka win 2012 Chemistry Nobel for GPCRs
Oct10

Lefkowitz and Kobilka win 2012 Chemistry Nobel for GPCRs

Defending the Chemistry Nobel for “biology” – again. I’m near-certain that this is the first Nobel Prize in Chemistry given to two MDs. (10:31 am EDT: I was wrong, as per commenter Jonny below. Peter Agre, MD, and Roderick MacKinnon, MD, received the Nobel Prize in Chemistry 2003 for their work on aquaporins and other ion channels.) Robert Lefkowitz, MD, of the Howard Hughes Medical Institute and Duke...

Read More
Gurdon and Yamanaka share Nobel Prize in Physiology or Medicine 2012
Oct08

Gurdon and Yamanaka share Nobel Prize in Physiology or Medicine 2012

British scientist John B. Gurdon and Shinya Yamanaka (MD, PhD!), a Japanese scientist now at the Gladstone Institutes in San Francisco, were awarded the Nobel Prize in Physiology or Medicine this morning,  “for the discovery that mature cells can be reprogrammed to become pluripotent.” Briefly, Gurdon and colleagues showed that the genetic information from a mature, differentiated cell still had the ability to program an...

Read More